Greycroft partners with bold founders in AI, software, sustainability, and consumer brands to create lasting impact. They believe AI will dominate the software category over the next decade and seek to support founders reimagining industries across these sectors.
About Greycroft
Greycroft is a multi-stage venture firm with offices in New York and Los Angeles and a thesis spanning consumer, enterprise, and selective healthcare investing, with a strong brand built on early bets in companies like Venmo, Bumble, and Trade Desk. The firm operates separate seed and growth funds, with the seed fund focused on early-stage and the growth fund leading later rounds. For healthcare AI founders, Greycroft is a credible generalist with selective healthcare exposure rather than a healthcare specialist; the firm has done meaningful digital health and healthcare technology deals but does not lead with a healthcare-specific thesis. Plausible check sizes vary substantially by fund: 250K to 2M at seed, 5M to 25M at growth. The firm leads or co-leads at all stages. Founders building healthcare AI with strong B2B SaaS or consumer characteristics, category-defining ambition, and clear technical defensibility should approach. Founders pitching deep biotech, regulated medical devices, or research-stage clinical AI should look at life sciences specialists; Greycroft does not advertise that depth. Entry path is warm introduction through portfolio founders or operator networks in New York or Los Angeles, or LinkedIn outreach to partners (Dana Settle, Alan Patricof, others have public profiles). The firm reads inbound but the signal-to-noise is heavy. Diligence will be sharp on team, market structure, defensibility, and unit economics. Expect a generalist read with light healthcare market context. The value-add includes New York and LA network access, brand-driven syndicate signaling, and follow-on capacity from a multi-stage platform. Bring evidence of category leadership ambition and clear product-market traction.
Founder reviews
Healthcare AI tools backed by Greycroft
Tools made by companies in Greycroft's portfolio that we cover in the directory.
Portfolio companies in our directory
Other portfolio companies
Companies in Greycroft's portfolio not currently in our directory.
- Sequen AI · 2025
- Penguin AI · 2024
- Playhouse MD · 2025
- Biologica
- Boulder Care
- Budgie Health
- Calibrate Health
Team
Pitch / review this investor
Have you raised from Greycroft? Founders only — share your honest experience (anonymous OK, moderated before publishing).